Alsadhan, A., Cheung, J., Gulrajani, M., Gaglione, E. M., Nierman, P., Hamdy, A., . . . Wiestner, A. (2020). Pharmacodynamic analysis of BTK inhibition in patients with chronic lymphocytic leukemia treated with acalabrutinib. Clin Cancer Res.
Chicago-stil citatAlsadhan, Anfal, et al. "Pharmacodynamic Analysis of BTK Inhibition in Patients With Chronic Lymphocytic Leukemia Treated With Acalabrutinib." Clin Cancer Res 2020.
MLA-referensAlsadhan, Anfal, et al. "Pharmacodynamic Analysis of BTK Inhibition in Patients With Chronic Lymphocytic Leukemia Treated With Acalabrutinib." Clin Cancer Res 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.